OTCMKTS:GLUC Glucose Health (GLUC) Stock Price, News & Analysis $0.09 +0.00 (+2.28%) As of 08/29/2025 12:35 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesSEC FilingsBuy This Stock About Glucose Health Stock (OTCMKTS:GLUC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Glucose Health alerts:Sign Up Key Stats Today's Range$0.09▼$0.1050-Day Range$0.08▼$0.1152-Week Range$0.08▼$0.28Volume9,318 shsAverage Volume5,559 shsMarket Capitalization$1.64 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas. Read More Receive GLUC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Glucose Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GLUC Stock News HeadlinesThe size of your neck can predict your risk of heart disease and diabetes — how many inches is too bigAugust 31 at 2:39 AM | nypost.comNThese Three Simple Lifestyle Changes Can Help Cut Your Risk Of Diabetes By 31 PercentAugust 30 at 11:18 AM | msn.comForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it could transform warfare, robotics, and the global economy. But you don’t need to buy Tesla or wait for xAI to IPO to benefit. One overlooked public company is supplying the critical tech behind Musk’s AI push — and it trades for a fraction of Nvidia’s price. Hedge funds are already loading up, but most investors haven’t noticed yet.September 1 at 2:00 AM | Behind the Markets (Ad)Metabolic health plays larger role than weight gain in pregnancy outcomesAugust 28, 2025 | msn.comDiabetes-detecting breath test shows early promise in trialAugust 28, 2025 | msn.comJoy Bauer's 3-Day Meal Plan to Reset Your Blood SugarAugust 27, 2025 | msn.comWhy people with diabetes should include jamun in their diet: Know its benefitsAugust 27, 2025 | msn.comBreath Test For Diabetes Under DevelopmentAugust 27, 2025 | usnews.comSee More Headlines GLUC Stock Analysis - Frequently Asked Questions How have GLUC shares performed this year? Glucose Health's stock was trading at $0.12 at the beginning of the year. Since then, GLUC stock has decreased by 21.6% and is now trading at $0.0941. How were Glucose Health's earnings last quarter? Glucose Health, Inc. (OTCMKTS:GLUC) posted its quarterly earnings data on Friday, August, 8th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.08 million for the quarter. How do I buy shares of Glucose Health? Shares of GLUC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Glucose Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Glucose Health investors own include Celsius (CELH), AGNC Investment (AGNC), Brixmor Property Group (BRX), Flaherty & Crumrine Total Return Fund (FLC), abrdn Healthcare Investors (HQH), NVIDIA (NVDA) and Company Calendar Last Earnings8/08/2025Today9/01/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED PRODUCTS Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:GLUC CIK1420108 Webwww.glucosehealthinc.com Phone(479) 802-3827FaxN/AEmployees147,000Year Founded2014Profitability EPS (Trailing Twelve Months)($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$320 thousand Net Margins-82.29% Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$380 thousand Price / Sales4.31 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares17,412,000Free FloatN/AMarket Cap$1.64 million OptionableNot Optionable Beta1.76 Social Links Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (OTCMKTS:GLUC) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersNew Banking Law #1582 Could Unlock $21 Trillion for AmericansDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Glucose Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Glucose Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
